Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in Am Heart J

Retrieve available abstracts of 60 articles:
HTML format

Single Articles

    November 2022
  1. STAMBLER BS, Plat F, Sager PT, Lubkov V, et al
    Rationale for and design of a multicenter, placebo-controlled, phase 3 study to assess efficacy and safety of intranasal etripamil for the conversion of paroxysmal supraventricular tachycardia.
    Am Heart J. 2022;253:20-29.
    PubMed     Abstract available

    September 2022
  2. ZEITLER EP, Bunch TJ, Khanna R, Fan X, et al
    Comparative risk of dementia among patients with atrial fibrillation treated with catheter ablation versus anti-arrhythmic drugs.
    Am Heart J. 2022;254:194-202.
    PubMed     Abstract available

  3. BRIK T, Lucassen WAM, Harskamp RE, Karregat EPM, et al
    Personalized approach using wearable technology for early detection of Atrial Fibrillation in high-risk primary care patients (PATCH-AF): study protocol for a cluster randomized controlled trial.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00185.
    PubMed     Abstract available

  4. NAKAMARU R, Ikemura N, Spertus JA, Kimura T, et al
    Rate versus Rhythm Control in Patients with Newly Diagnosed Atrial Fibrillation: Effects of the Treatment Timing on Health Status Outcomes.
    Am Heart J. 2022 Sep 10. pii: S0002-8703(22)00187.
    PubMed     Abstract available

    August 2022
  5. NERY PB, Wells GA, Verma A, Joza J, et al
    Am Heart J. 2022 Aug 25. pii: S0002-8703(22)00181.
    PubMed     Abstract available

    July 2022
  6. SCHOLTEN J, Jansen WPJ, Horsthuis T, Mahes AD, et al
    Six-lead device superior to single-lead smartwatch ECG in atrial fibrillation detection.
    Am Heart J. 2022 Jul 15. pii: S0002-8703(22)00143.
    PubMed     Abstract available

  7. WINSLOW U, Sakthivel T, Zheng C, Bosselmann H, et al
    Targeted potassium levels to decrease arrhythmia burden in high risk patients with cardiovascular diseases (POTCAST): Study protocol for a randomized controlled trial.
    Am Heart J. 2022 Jul 11. pii: S0002-8703(22)00145.
    PubMed     Abstract available

    June 2022
  8. DIXON D, Patel J, Spence R, Talasaz A, et al
    Select Drug-Drug Interactions with Colchicine and Cardiovascular Medications: A Review.
    Am Heart J. 2022 Jun 14. pii: S0002-8703(22)00126.
    PubMed     Abstract available

  9. MAGNANI JW, Ferry D, Swabe G, Martin D, et al
    Design and rationale of the Mobile health intervention for rural atrial fibrillation.
    Am Heart J. 2022 Jun 9. pii: S0002-8703(22)00117.
    PubMed     Abstract available

    The safety of flecainide for atrial fibrillation in patients with stable coronary artery disease - Fact or fallacy.
    Am Heart J. 2022;248:163-164.

    May 2022
  11. AULIN J, Hijazi Z, Lindback J, Alexander JH, et al
    Biomarkers and heart failure events in patients with atrial fibrillation in the ARISTOTLE trial evaluated by a multistate model.
    Am Heart J. 2022 May 12. pii: S0002-8703(22)00091.
    PubMed     Abstract available

  12. OKAZAKI O, Higashino Y, Yokoya K, An Y, et al
    Prognosis of elderly non-valvular atrial fibrillation patients stratified by B-type natriuretic peptide: ELDERCARE-AF subanalysis.
    Am Heart J. 2022 May 11. pii: S0002-8703(22)00094.
    PubMed     Abstract available

  13. GWAG HB, Kim HR, Park SJ, Kim J, et al
    The efficacy of single-lead implantable cardioverter-defibrillator with atrial sensing dipole to detect atrial fibrillation and to reduce inappropriate therapy according to atrial sensing ON or OFF: Rationale and design of the SMART-CONTROL study, a p
    Am Heart J. 2022 May 11. pii: S0002-8703(22)00090.
    PubMed     Abstract available

  14. LOPEZ-GALVEZ R, Marin F, Rivera-Caravaca JM
    Predicting heart failure in atrial fibrillation patients: What about using biomarkers?
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00092.

  15. HUIJBOOM HFM, Maarse M, Aarnink E, van Dijk VF, et al
    COMPARE LAAO: Rationale and design of the randomized controlled trial 'COMPARing Effectiveness and safety of Left Atrial Appendage Occlusion to standard of care for atrial fibrillation patients at high stroke risk and ineligible to use oral anticoagul
    Am Heart J. 2022 May 7. pii: S0002-8703(22)00085.
    PubMed     Abstract available

  16. WAZNI O, Boersma L, Healey JS, Mansour M, et al
    Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation: Rationale and Design of the OPTION randomized trial.
    Am Heart J. 2022 May 5. pii: S0002-8703(22)00088.
    PubMed     Abstract available

  17. GAO W, Zhong X, Ma Y, Huang D, et al
    A Randomized Multicenter Trial to Evaluate Early Invasive Strategy for Patients with Acute ST-segment Elevation Myocardial Infarction Presenting 24-48 Hours from Symptom Onset: protocol of the RESCUE-MI study.
    Am Heart J. 2022 May 4. pii: S0002-8703(22)00087.
    PubMed     Abstract available

    April 2022
  18. SINGER DE, Atlas SJ, Go AS, Lopes RD, et al
    ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and Design of the GUARD-AF Randomized Trial of Screening for Atrial Fibrillation with a 14-day Patch-Based Continuous ECG Monitor.
    Am Heart J. 2022 Apr 23. pii: S0002-8703(22)00080.
    PubMed     Abstract available

    February 2022
  19. NAIR GM, Birnie DH, Wells GA, Nery PB, et al
    Augmented Wide Area Circumferential Catheter Ablation for Reduction of Atrial Fibrillation Recurrence (AWARE) Trial: Design and Rationale.
    Am Heart J. 2022 Feb 24. pii: S0002-8703(22)00043.
    PubMed     Abstract available

  20. JONES AE, McCarty MM, Brito JP, Noseworthy PA, et al
    Randomized Evaluation of Decision Support Interventions for Atrial Fibrillation: Rationale and Design of the RED-AF study.
    Am Heart J. 2022 Feb 23. pii: S0002-8703(22)00042.
    PubMed     Abstract available

  21. CHO MS, Kang DY, Oh YS, Lee CH, et al
    Edoxaban-Based Long-Term Antithrombotic Therapy in Patients with Atrial Fibrillation and Stable Coronary Disease: Rationale and Design of the Randomized EPIC-CAD Trial.
    Am Heart J. 2022 Feb 8. pii: S0002-8703(22)00023.
    PubMed     Abstract available

  22. CHANG PC, Wen MS, Chou CC, Wang CC, et al
    Atrial Fibrillation Detection Using Ambulatory Smartwatch Photoplethysmography and Validation with Simultaneous Holter Recording.
    Am Heart J. 2022 Feb 4. pii: S0002-8703(22)00028.
    PubMed     Abstract available

    January 2022
  23. BAYKANER T, Pundi K, Lin B, Lu Y, et al
    The ENHANCE-AF Clinical Trial to Evaluate an Atrial Fibrillation Shared Decision-Making Pathway: Rationale and Study Design.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00013.
    PubMed     Abstract available

  24. KLINGENBERG R, Stahli BE, Heg D, Denegri A, et al
    Controlled-Level EVERolimus in Acute Coronary Syndrome (CLEVER-ACS) - A phase II, randomized, double-blind, multi-center, placebo-controlled trial.
    Am Heart J. 2022 Jan 26. pii: S0002-8703(22)00010.
    PubMed     Abstract available

  25. ECKMAN MH, Wise R, Knochelmann C, Mardis R, et al
    Electronic Health Record-Embedded Decision Support to Reduce Stroke Risk in Patients with Atrial Fibrillation - Study Protocol.
    Am Heart J. 2022 Jan 23. pii: S0002-8703(22)00012.
    PubMed     Abstract available

  26. GENCER B, Eisen A, Berger D, Nordio F, et al
    Edoxaban vs. Warfarin in High-risk Patients with Atrial Fibrillation: A Comprehensive Analysis of High-Risk Subgroups.
    Am Heart J. 2022 Jan 3. pii: S0002-8703(21)00499.
    PubMed     Abstract available

  27. FARJAT AE, Virdone S, Thomas LE, Kakkar AK, et al
    The importance of the design of observational studies in comparative effectiveness research: Lessons from the GARFIELD-AF and ORBIT-AF registries.
    Am Heart J. 2022;243:110-121.
    PubMed     Abstract available

    December 2021
  28. HIGGINS AY, Annapureddy AR, Wang Y, Minges KE, et al
    Risk and Predictors of Mortality After Implantable Cardioverter-Defibrillator Implantation in Patients with Sarcoid Cardiomyopathy.
    Am Heart J. 2021 Dec 27. pii: S0002-8703(21)00491.
    PubMed     Abstract available

  29. ULLAL AJ, Holmes DN, Lytle BL, Matsouaka RA, et al
    Achievement and Quality Measure Attainment in Patients Hospitalized with Atrial Fibrillation: Results from the Get With The Guidelines(R) - Atrial Fibrillation (GWTG-AFIB) Registry.
    Am Heart J. 2021 Dec 18. pii: S0002-8703(21)00475.
    PubMed     Abstract available

  30. PAVLOVIC N, Chierchia GB, Velagic V, Hermida JS, et al
    Initial rhythm control with cryoballoon ablation vs drug therapy: Impact on quality of life and symptoms.
    Am Heart J. 2021;242:103-114.
    PubMed     Abstract available

    November 2021
  31. STEINBERG BA, Li Z, Shrader P, Chew DS, et al
    Clinical Investigations Bimodal Distribution of Atrial Fibrillation Burden in 3 Distinct Cohorts: What is 'Paroxysmal' Atrial Fibrillation?
    Am Heart J. 2021 Nov 24. pii: S0002-8703(21)00464.
    PubMed     Abstract available

  32. ANTONIO GUTIERREZ J, Ruff CT, Aday AW, Gu L, et al
    Electronic Alerts to Initiate Anticoagulation Dialogue in Patients with Atrial Fibrillation.
    Am Heart J. 2021 Nov 19. pii: S0002-8703(21)00452.
    PubMed     Abstract available

  33. CHEW DS, Li Z, Steinberg BA, O'Brien E, et al
    Association between Economic and Arrhythmic Burden of Paroxysmal Atrial Fibrillation in Patients with Cardiac Implanted Electronic Devices.
    Am Heart J. 2021 Nov 17. pii: S0002-8703(21)00450.
    PubMed     Abstract available

  34. MERT GO, Babayigit E, Gorenek B
    The value of performing thorough echocardiography in patients with coronary heart disease and atrial fibrillation.
    Am Heart J. 2021;241:121.

  35. TOMASDOTTIR M, Held C, Wallentin L, Hijazi Z, et al
    Natriuretic peptides and incident atrial fibrillation.
    Am Heart J. 2021;241:120.

  36. DAILEY-SCHWARTZ AL, Dyal JA, Mahle WT, Oster ME, et al
    Implementation of a practice plan for the outpatient cardiac evaluation of children after acute SARS-CoV-2 infection and a report of outcomes.
    Am Heart J. 2021;241:83-86.
    PubMed     Abstract available

    October 2021
  37. AKDIS D, Chen L, Saguner AM, Zhang N, et al
    Novel Plasma Biomarkers Predicting Biventricular Involvement in Arrhythmogenic Right Ventricular Cardiomyopathy: Novel Biomarkers in ARVC.
    Am Heart J. 2021 Oct 28. pii: S0002-8703(21)00441.
    PubMed     Abstract available

  38. ARITA VA, Santema BT, De With RR, Nguyen BO, et al
    Atrial function in paroxysmal AF patients with and without heart failure with preserved ejection fraction: data from the AF-RISK study.
    Am Heart J. 2021 Oct 21. pii: S0002-8703(21)00435.
    PubMed     Abstract available

  39. PICCINI JP, Ahlsson A, Dorian P, Gillinov MA, et al
    Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation - The NOVA Study.
    Am Heart J. 2021 Oct 20. pii: S0002-8703(21)00366.
    PubMed     Abstract available

  40. RASMUSSEN PV, Blanche P, Dalgaard F, Gislason GH, et al
    Electrical cardioversion of atrial fibrillation and the risk of brady-arrhythmic events: Rasmussen et al: Electrical cardioversion and bradycardia.
    Am Heart J. 2021 Oct 16. pii: S0002-8703(21)00434.
    PubMed     Abstract available

  41. CHIENG D, Sugumar H, Ling LH, Segan L, et al
    Catheter Ablation for Persistent Atrial Fibrillation: a Multicentre Randomised Trial of Pulmonary Vein Isolation (PVI) versus PVI with Posterior Left Atrial Wall Isolation (PWI) - the CAPLA Study: CAPLA: randomised trial for persistent AF.
    Am Heart J. 2021 Oct 4. pii: S0002-8703(21)00245.
    PubMed     Abstract available

    September 2021
  42. KORSHOLM K, Damgaard D, Valentin JB, Packer EJS, et al
    Left Atrial Appendage Occlusion versus Novel Oral Anticoagulation for Stroke Prevention in Atrial Fibrillation: Rationale and Design of the Multicenter Randomized Occlusion-AF Trial.
    Am Heart J. 2021 Sep 16. pii: S0002-8703(21)00226.
    PubMed     Abstract available

  43. BURNHAM TS, May HT, Bair TL, Anderson JA, et al
    Long-term Outcomes in Patients Treated with Flecainide for Atrial Fibrillation with Stable Coronary Artery Disease.
    Am Heart J. 2021 Sep 16. pii: S0002-8703(21)00211.
    PubMed     Abstract available

  44. KIM K, Yang PS, Jang E, Yu HT, et al
    Increased risk of ischemic stroke and systemic embolism in hyperthyroidism-related atrial fibrillation: A nationwide cohort study.
    Am Heart J. 2021 Sep 1. pii: S0002-8703(21)00224.
    PubMed     Abstract available

    August 2021
  45. DAWWAS GK, Barnes GD, Dietrich E, Cuker A, et al
    Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation A population-based analysis.
    Am Heart J. 2021 Aug 24. pii: S0002-8703(21)00212.
    PubMed     Abstract available

  46. BONNESEN MP, Diederichsen SZ, Isaksen JL, Frederiksen KS, et al
    Atrial Fibrillation Burden and Cognitive Decline in Elderly Patients Undergoing Continuous Monitoring.
    Am Heart J. 2021 Aug 21. pii: S0002-8703(21)00204.
    PubMed     Abstract available

  47. HAWKINS NM, Er L, Sandhu RK, Kaul P, et al
    Validity of different dose reduction criteria for apixaban.
    Am Heart J. 2021;238:12-15.
    PubMed     Abstract available

    July 2021
  48. CHRISTENSEN DM, Butt JH, Fosbol E, Kober L, et al
    Admission Rates During a Second COVID-19 Lockdown.
    Am Heart J. 2021 Jul 15. pii: S0002-8703(21)00180.
    PubMed     Abstract available

  49. FREYER L, von Stulpnagel L, Spielbichler P, Sappler N, et al
    Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based Bavarian Alternative Detection of Atrial Fibrillation (eBRAVE-AF) trial.
    Am Heart J. 2021 Jul 9. pii: S0002-8703(21)00164.
    PubMed     Abstract available

    June 2021
  50. KUMAR N, Xu H, Garg N, Pandey A, et al
    Patient Characteristics, Care Patterns, and Outcomes of Atrial Fibrillation Associated Hospitalizations in Patients with Chronic Kidney Disease and End-Stage Renal Disease.
    Am Heart J. 2021 Jun 30. pii: S0002-8703(21)00175.
    PubMed     Abstract available

  51. WHEELOCK KM, Kratz A, Lathkar-Pradhan S, Najarian K, et al
    Association between Symptoms, Affect and Heart Rhythm in Patients with Persistent or Paroxysmal Atrial Fibrillation: An Ambulatory Pilot Study.
    Am Heart J. 2021 Jun 19. pii: S0002-8703(21)00150.
    PubMed     Abstract available

  52. SZUMMER K, Perino AC, Fan J, Kothari M, et al
    Association of kidney function and atrial fibrillation progression to clinical outcomes in patients with cardiac implantable electronic devices.
    Am Heart J. 2021 Jun 9. pii: S0002-8703(21)00149.
    PubMed     Abstract available

    May 2021
  53. KITTIPIBUL V, Blumer V, Hernandez GA, Fudim M, et al
    Pre-operative Atrial Fibrillation and Early Right Ventricular Failure after Left Ventricular Assist Device Implantation: A Systematic Review and Meta-Analysis.
    Am Heart J. 2021 May 23. pii: S0002-8703(21)00138.
    PubMed     Abstract available

  54. YAO X, Attia ZI, Behnken EM, Walvatne K, et al
    Batch Enrollment for an Artificial Intelligence-Guided Intervention to Lower Neurologic Events in Patients with Undiagnosed Atrial Fibrillation (BEAGLE): Rationale and design of a digital clinical trial.
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00135.
    PubMed     Abstract available

  55. HESS PL, Gosch KL, Jani SM, Varosy PD, et al
    Use of Oral Anticoagulants in Patients with Valvular Atrial Fibrillation: Findings From the NCDR PINNACLE Registry(R).
    Am Heart J. 2021 May 22. pii: S0002-8703(21)00120.
    PubMed     Abstract available

  56. GRUBB CS, Truby LK, Topkara VK, Bohnen MS, et al
    Advanced Heart Failure Patients Supported with Ambulatory Inotropic Therapy: What Defines Success of Therapy?
    Am Heart J. 2021 May 10. pii: S0002-8703(21)00121.
    PubMed     Abstract available

  57. MADSEN JMM, Jacobsen MRR, Sabbah M, Topal DGG, et al
    Long-Term Prognostic Outcomes and Implication of Oral Anticoagulants in Patients with New-Onset Atrial Fibrillation following ST-Segment Elevation Myocardial Infarction.
    Am Heart J. 2021 May 3. pii: S0002-8703(21)00114.
    PubMed     Abstract available

    April 2021
  58. LUBITZ SA, Faranesh AZ, Atlas SJ, McManus DD, et al
    Rationale and Design of a Large Population Study to Validate Software for the Assessment of Atrial Fibrillation from Data Acquired by a Consumer Tracker or Smartwatch: The Fitbit Heart Study.
    Am Heart J. 2021 Apr 15. pii: S0002-8703(21)00093.
    PubMed     Abstract available

  59. MARTIN AC, Hausleiter J, Karam N
    Intra-procedural unfractionated heparin monitoring and uninterrupted direct oral anticoagulants: An unheeded issue in transcatheter mitral valve repair procedures.
    Am Heart J. 2021;234:136-137.

    March 2021
  60. KIVINIEMI T, Bustamante-Munguira J, Olsson C, Jeppsson A, et al
    A randomized prospective multicenter trial for stroke prevention by prophylactic surgical closure of the left atrial appendage in patients undergoing bioprosthetic aortic valve surgery - LAA-CLOSURE trial protocol.
    Am Heart J. 2021 Mar 30. pii: S0002-8703(21)00087.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.